Increasing Incidence of Atrial Fibrillation, Technological Innovations in Ablation Procedures, and Expanding Electrophysiology Labs Fuel Robust Market Expansion.Austin, United States, March 19, 2026 ...
Clinical Trials Arena on MSN
CellProthera sets the scene for Phase III stem cell therapy trial
The biotech will soon evaluate the safety and efficacy of its regenerative cardiovascular stem cells, coined ProtheraCytes, ...
Global cardiac surgery device market will grow from $21.1B in 2025 to $30.8B by 2032, driven by advances in imaging, ...
Healthgrades has announced the recipients of the 2026 Patient Safety Excellence Awards which recognize hospitals that provide ...
The Environmental Protection Agency has proposed weakening air pollution limits for a chemical used to sterilize medical ...
First real-world validation of China’s YDHB-NS01 shows 100% success, shorter procedures than manual angiography, and no ...
ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera™ Mapping ...
Verve Medical’s therapy targets overactive renal nerves US-based Verve Medical has reported the treatment of the first patient in its pilot trial for uncontrolled hypertension with a renal pelvic ...
Heart disease continues to be one of the leading health concerns in India, making timely diagnosis and expert treatment more important than ever.
Like whale blubber, oil as a dominant source of energy will gradually be phased out over the next decades. Here's what that transition may look like. When you purchase through links on our site, we ...
According to Healthgrades' annual analysis, if all hospitals performed as well as the 2026 Patient Safety Excellence Award winners, 100,819 patient safety events could have been avoided between 2022 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results